Stability studies of alprazolam tablets: Effects of chemical interactions with some excipients in pharmaceutical solid preparations

Journal of Physical Organic Chemistry

Volumn 22, Issue 9, 2009, Pages 807-814

  Cast̃arieda, Beatriz ^a   Ortiz Cala, William ^a   Gallardo Cabrera, Cecilia ^a   Nudelman, Norma Sbarbati ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Alprazolam tablets stability; Alprazolam; degradation; Chemical interactions; Excipients effects; triazolaminoquinoleine; Incompatibility

Indexed keywords

ALPRAZOLAM DEGRADATION; ALPRAZOLAM TABLETS STABILITY; CHEMICAL INTERACTIONS; EXCIPIENTS EFFECTS TRIAZOLAMINOQUINOLEINE; INCOMPATIBILITY;

CHEMICAL STABILITY; DRUG PRODUCTS; MAGNESIUM; STABILITY; SUGARS;

DEGRADATION;

EID: 68949221545     PISSN: 08943230     EISSN: 10991395     Source Type: Journal    
DOI: 10.1002/poc.1523     Document Type: Article

References (29)

1. L. M. Loscalzo, C. Wasowski, A. C. Paladini, M. Marder, Eur J Pharmacol. 2008, 580, 306-313
2. M. Alajarín, J. Cabrera, A. Pastor, J. M. Villalgordo, Tetrahedron Lett. 2007, 48, 3495-3499
3. H. Novoa de Armas, O. M. Peeters, G. Van Den Mooter, N. Blaton, J. Pharm. Sci. 2007, 96, 1114-1130
4. F. Masśe, M. Hascoët, M. Bourin, Eur. Neuropsychopharmacol. 2007, 17, 483-491
5. M. Béchir, K. Schwegler, R. Chenevard, C. Binggeli, C. Caduff, S. Büchi, C. Buddeberg, T. F. Lüscher, G. Noll, Auton. Neurosci. 2007, 134, 69-73
6. M. Okamura, N. Akizuki, T. Nakano, K. Shimizu, T. Ito, T. Akechi, Y. Uchitomi, Psychooncology 2008, 17, 154-160
7. K. S. Bhogal, D. S. Baldwin, Psychiatry 2007, 6, 217-223
8. I. Cepanec, M. Litvic, I. Pagorelic, Org. Process Res. Dev. 2006, 10, 1192-1198
9. M. N. Uddin, V. F. Samanidou, I. N. Papadoyannis, J. Liq. Chromatogr. Relat. Technol. 2008, 31, 1258-1282
10. L. Saavedra, A. L. Huidobro, A. Garcia, J. C. Cabanelas, M. G. Gonzalez, C. Barbas, Electrophoresis 2005, 27, 2360-2366
11. S. K. Leonard, J. M. Dwyer, S. J. S. Rizzo, B. Platt, S. F. Logue, S. J. Neal, J. E. Malberg, C. E. Beyer, L. E. Schechter, S. Rosenzweig-Lipson, R. H. Ring, Psychopharmacology 2008, 197, 601-611
12. A. Singh, A. Kumar, Neurosci. Res. 2008, 60, 372-379
13. K. O'Connor, A. Marchand, L. Brousseau, F. Aardemia, V. Lafrance, S. Bolvin, D. Pitre, S. Robillard, D. Bouthilier, Clin. Psychol. Psychother. 2008, 15, 1-14
14. N. S. Nudelman, R. G. de Waisbaum, C. Gallardo, J. Phys. Org. Chem. 2005, 18, 156-161
15. N. S. Nudelman, C. Gallardo, J. Pharm. Biomed. Anal. 2002, 30, 887-893
16. N. S. Nudelman, C. Gallardo, Vitae 1999, 6, 29-40
17. N. S. Nudelman, C. Gallardo, J. Pharm. Sci. 2002, 91, 1274-1286
18. C. Gallardo, Y. Tobón, S. M. López, Vitae 2003, 10, 35-43
19. V. H. Thomas, M. Naath, Int. J. Pharm. 2008, 359, 150-157
20. A. V. Zinchuka, B. C. Hancocka, E. Y. Shalaeva, R. D. Reddya, R. Govindarajanb, E. Novaka, Eur J Pharm. Biopharm. 2005, 20, 1-13
21. M. L. González-Rodríguez, L. B. Barros, J. Palma, P. L. González- Rodríguez, A. M. Rabasco, Int. J. Pharm. 2007, 337, 336-345
22. M. J. Cho, T. A. Scahill, J. B. Hester, J. Pharm. Sci. 1983, 72, 62-356
23. R. M. Jiménez, E. Domínguez, D. Baía, R. M. Alonso, F. Vicente, J. Heterocyl. Chem. 1987, 24, 421
24. P. Pérez-Lozano, E. García-Montoya, A. Orriols, M. Miñarro, J. R. Ticó, J. M. Suñé-Negre, J. Pharm. Biomed. Anal. 2004, 34, 979-987
25. C. Barbas, F. J. Rupérez, A. L. Huidobro, J. Pharm. Biomed. Anal. 2007, 44, 404-413
26. D. C. Montgomery, Diseñio y Anásis de Experimentos, Grupo editorial Iberoamericana, México, 1991, 299-338
27. M. Ogata, T. Hahara, T. Nishimura, J. Pharm. Sci. 1995, 84, 786-790
28. Y. Mori, M. Konishi, K. Hirai, J. Pharm. Sci. 1982, 71, 1328-1334
29. M. S. Gordon, M. Brandl, A. Magill, V. Rudraraju, J. Pharm. Sci. 1995, 84, 1151-1153.